HealthTab™ to Integrate CONTOUR®NEXT Family of B

VANCOUVER, British Columbia, July 19, 2023 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce its agreement with Ascensia Diabetes Care, a global diabetes care company, to integrate their blood glucose monitoring (BGM) systems, marketed as CONTOUR®NEXT GEN and CONTOUR®NEXT ONE, with Avricore’s pharmacy-based point-of-care testing (POCT) platform, HealthTab. Ascensia Diabetes Care is a subsidiary of PHC Holdings Corporatio

Related Keywords

Vancouver , British Columbia , Canada , United Kingdom , United States , British , Canadians , Americans , Hector Bremner , Annika Pawaroo , Avricore Health , Avricore Health Inc , Holdings Corporation , Ascensia Diabetes Care Canada Inc , Health Inc , Ascensia Diabetes Care , Region Americas , Ascensia Diabetes , Diabetes Care , Continuous Glucose Monitoring Systems , Diabetes Care Canada , Lipid Profile , Care Testing Market , Healthtab , Blood Glucose Monitoring , Diabetes Management , Ascensia , Pharmacists , Diabetes , Health Care Provider ,